These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29926655)

  • 1. [Effects of hydrogen sulfide (H
    Wu Y; Guo YY; Zhang YY; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MicroRNA-133a attenuates isoproterenol-induced neonatal rat cardiomyocyte hypertrophy by downregulating L-type calcium channel α1C subunit gene expression].
    Wu Y; Wang YQ; Wang BX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):507-13. PubMed ID: 24113045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
    Sugiyama A; Okada M; Yamawaki H
    Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
    Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway.
    Liu XP; Gao H; Huang XY; Chen YF; Feng XJ; He YH; Li ZM; Liu PQ
    Transl Res; 2015 Nov; 166(5):459-473.e3. PubMed ID: 26118953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells.
    Asadi F; Razmi A; Dehpour AR; Shafiei M
    J Pharm Pharmacol; 2016 Apr; 68(4):485-93. PubMed ID: 26945895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.
    Li Q; Lin X; Yang X; Chang J
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1340-7. PubMed ID: 20173049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFAT regulation of cystathionine γ-lyase expression in endothelial cells is impaired in rats exposed to intermittent hypoxia.
    Gonzalez Bosc LV; Osmond JM; Giermakowska WK; Pace CE; Riggs JL; Jackson-Weaver O; Kanagy NL
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H791-H799. PubMed ID: 28130342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFATc4 and myocardin synergistically up-regulate the expression of LTCC α1C in ET-1-induced cardiomyocyte hypertrophy.
    Li M; He HP; Gong HQ; Zhang J; Ma WJ; Zhou H; Cao DS; Wang N; Zhang TC
    Life Sci; 2016 Jun; 155():11-20. PubMed ID: 27155398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
    Zhang X; Xia J; Qian D; Wang Y; Lin Y; Huang X; Tan J
    Cardiology; 2014; 129(3):153-62. PubMed ID: 25277512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of relgulation of PPAR-α on cardiac hypertrophy and the relationship between the effect of PPAR-α with PI3K/Akt/mTOR pathway].
    Wu Y; Wang BX; Guo YY; Wang YQ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):284-8. PubMed ID: 26387199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
    Liou SF; Hsu JH; Chen YT; Chen IJ; Yeh JL
    Molecules; 2015 Jun; 20(6):10435-49. PubMed ID: 26056815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
    Chen Y; Yuan J; Jiang G; Zhu J; Zou Y; Lv Q
    Mol Med Rep; 2017 Oct; 16(4):4545-4552. PubMed ID: 28849081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen sulphide inhibits cardiomyocyte hypertrophy by up-regulating miR-133a.
    Liu J; Hao DD; Zhang JS; Zhu YC
    Biochem Biophys Res Commun; 2011 Sep; 413(2):342-7. PubMed ID: 21893044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
    Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAKα2 inhibits fibrosis formation and protects against cardiomyocyte hypertrophy by suppressing hypertrophy associated molecules and activating LTCC/NCX signaling pathway.
    Song SS; Tang G; Tang LX; Si LY; Xiong W
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):3021-3033. PubMed ID: 31002153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.